关键词：中心疾病控制与预防中心（CDC）；疫苗；免疫系统产生；可预防；人类疫苗供成人；儿童使用
摘 要：According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose. Human vaccines are of two types: preventable human vaccines and therapeutic human vaccines. Preventable human vaccines are used both for adults and children. Pediatric human vaccines are used to immunize children against various infectious diseases such as diphtheria, influenza, hepatitis, pneumococcal diseases, and meningococcal diseases. According to the classification adopted by the US FDA, children are classified as newborn, infant, child, and adolescent, ranging from birth to 21 years of age. However, the European Medicines Association (EMA) classifies pediatrics ranging from birth to 18 years of age. Therapeutic vaccine is a biological entity developed for inducing attack against a diseased cell or tissue. There are two approved therapeutic vaccines namely Provenge and Oncophage. A large number of therapeutic vaccines are under clinical development and are expected to be launched during the forecast period.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Vaccine approval process

Vaccines price list

PART 06: Pipeline portfolio

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 08: Market segmentation by type of human vaccine

Live attenuated vaccine

Killed vaccine

Toxoid vaccine

Genetically modified/engineered vaccine

Synthetic vaccines

Dendritic cells vaccines

Conjugate vaccines

Subunit vaccines

PART 09: Market segmentation by composition

Mono vaccine

Combination vaccines

PART 10: Market segmentation by route of administration

Oral vaccines

Intramuscular vaccines

Intranasal vaccines

Intradermal vaccines

PART 11: Market segmentation by type of human vaccine

PART 12: Global therapeutic human vaccines market

Market overview

Market size and forecast

PART 13: Global preventable human vaccines market

Market overview

Market size and forecast

PART 14: Global pediatric preventable human vaccines market

Market size and forecast

PART 15: Global adult preventable human vaccines market

Market size and forecast

PART 16: Geographical segmentation

Human vaccines market in the Americas

Market size and forecast

Human vaccines market in EMEA

Market size and forecast

Human vaccines market in APAC

Market size and forecast

PART 17: Market drivers

Growing awareness about vaccination and immunization programs

Inclusion in national immunization schedule

High demand for pediatric vaccines

Increase in prevalence of infectious diseases

PART 18: Impact of drivers

PART 19: Market challenges

Inadequate vaccination coverage

Vaccine storage and handling issues

High risk associated with vaccine development

Stringent regulatory process

Misperception about vaccines

Adverse side effects of vaccines

PART 20: Impact of drivers and challenges

PART 21: Market trends

Increase in strategic alliance and M&A

Entry of novel vaccines

Increase in investment

Focus on emerging markets

Emergence of resistant strains

Public-private initiatives

PART 22: Vendor landscape

Competitive scenario

PART 23: Key vendor analysis

GSK

Sanofi

Merck

Pfizer

Other prominent vendors

PART 24: Appendix

List of abbreviations

PART 25: Explore Technavio